Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cellsUlrike Olszewski, Robert Zeillinger, Klaus Geissler, et al.Journal of Experimental Pharmacology|May 18, 2016
Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cellsUlrike Olszewski, Ernst Ulsperger, Klaus Geissler, et al.Experimental and Therapeutic Medicine|November 9, 2012
Circulating cytokeratin 18 fragments and activation of dormant tumor cells in bone marrow of cancer patientsChristoph Ausch, Veronika Buxhofer-Ausch, Ulrike Olszewski, et al.Cancers|November 12, 2013
Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitroUlrike Olszewski, Richard Liedauer, Christoph Ausch, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 18, 2011
In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell linesWolfgang Fiebiger, Ulrike Olszewski, Ernst Ulsperger, et al.Molecular Medicine Reports|April 12, 2011
Anticancer drug cis-4-hydroxy-L-proline: Correlation of preclinical toxicology with clinical parameters of liver functionHeather Dickens, Anett Ullrich, Dieter Runge, et al.Oncology Reports|July 29, 2003
Effects of 1alpha,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factorsErnst Ulsperger, Gerhard Hamilton, Ulrike Olszewski, et al.Anti-Cancer Agents in Medicinal Chemistry|January 24, 2012
Anticancer effects of the organosilicon multidrug resistance modulator SILA 421Ulrike Olszewski, Robert Zeillinger, Meltem Demirel Kars, et al.Clinical Pharmacology : Advances and Applications|February 1, 2012
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compoundsUlrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al.Metal-Based Drugs|July 10, 2009
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer AgentUlrike Olszewski, Florian Ach, Ernst Ulsperger, et al.Pageof 10